[1] JOHNSON C O,NGUYEN M,ROTH G A,et al.Global,regional,and national burden of stroke,1990-2016:a systematic analysis for the global burden of disease study 2016[J].Lancet Neurol,2019,18(5):439-458.
[2] WU S,WU B,LIU M,et al.Stroke in China:advances and challenges in epidemiology,prevention,and management[J].Lancet Neurol,2019,18(4):394-405.
[3] WANG W,JIANG B,SUN H,et al.Prevalence,incidence,and mortality of stroke in China:results from a nationwide population-based survey of 480 687 adults[J].Circulation,2017,135(8):759-771.
[4] 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志，2018，51(9)：666-682.
[5] YAGHI S,BOEHME A K,DIBU J,et al.Treatment and outcome of thrombolysis-related hemorrhage:a multicenter retrospective study[J].JAMA Neurol,2015,72(12):1451-1457.
[6] MARCOS-CONTRERAS O A,MARTINEZ D L S,BARDOU I,et al.Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin-and bradykinin-dependent mechanism[J].Blood,2016,128(20):2423-2434.
[7] YAGHI S,EISENBERGER A,WILLEY J Z.Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator:a review of natural history and treatment[J].JAMA Neurol,2014,71(9):1181-1185.
[8] MUNDIYANAPURATH S,HEES K,AHMED N,et al.Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis:an analysis of the safe implementation of treatments in stroke registry[J].Eur J Neurol,2018,25(2):311-340.
[9] 王志华，罗良生.急性脑梗死患者继发出血性转化影响因素分析[J].现代医学，2016，44(11)：1596-1598.
[10] YAGHI S,WILLEY J Z,CUCCHIARA B,et al.Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke:a scientific statement for healthcare professionals from the american heart association/american stroke association[J].Stroke,2017,48(12):e343-e361.
[11] LI M,WANG Q,WANG Y L,et al.Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients:comparison of prediction models[J].J Stroke Cerebrovasc Dis,2015,24(6):1235-1243.
[12] 王彩玲，冯娟.急性脑梗死静脉溶栓后继发出血转化的危险因素及预测模型分析[J].中国医师杂志，2019，21(4)：540-543.
[13] QUINN T J,SINGH S,LEES K R,et al.Validating and comparing stroke prognosis scales[J].Neurology,2017,89(10):997-1002.
[14] ZHANG N,LIU G,ZHANG G,et al.External validation of the iScore for predicting ischemic stroke mortality in patients in China[J].Stroke,2013,44(7):1924-1929.
[15] SHEN B,YANG X,SUI R B,et al.The prognostic value of the THRIVE score,the iScore score and the ASTRAL score in Chinese patients with acute ischemic stroke[J].J Stroke Cerebrovasc Dis,2018,27(10):2877-2886.
[16] STRBIAN D,MICHEL P,SEIFFGE D J,et al.Symptomatic intracranial hemorrhage after stroke thrombolysis:comparison of prediction scores[J].Stroke,2014,45(3):752-758.
[17] BRUNING T,AL-KHALED M.Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA:the SEDAN score[J].CNS Neurosci Ther,2015,21(3):296-297.
[18] AL-KHALED M,LANGNER B,BRUNING T.Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue plasminogen activator using SEDAN score[J].Acta Neurol Scand,2016,133(4):239-244.
[19] ANDERSON C S,HUANG Y,LINDLEY R I,et al.Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke(ENCHANTED):an international,randomised,open-label,blinded-endpoint,phase 3 trial[J].Lancet,2019,393(10174):877-888.
[20] MÖBIUS C,BLINZLER C,SCHWAB S,et al.Re-evaluation of the stroke prognostication using age and NIH Stroke Scale index(SPAN-100 index) in IVT patients — the-SPAN 10065 index[J].BMC Neurol,2018,18(1):129.
[21] LEE H J,LEE J S,CHOI J C,et al.Simple estimates of symptomatic intracranial hemorrhage risk and outcome after intravenous thrombolysis using age and stroke severity[J].J Stroke,2017,19(2):229-231.
[22] KASTRUP A,BRUNNER F,HILDEBRANDT H,et al.THRIVE score predicts clinical and radiological outcome after endovascular therapy or thrombolysis in patients with anterior circulation stroke in everyday clinical practice[J].Eur J Neurol,2017,24(8):1032-1039.
[23] FLINT A C,GUPTA R,SMITH W S,et al.The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous rtPA administration in SITS-MOST[J].Int J Stroke,2014,9(6):705-710.
[24] CHEN W,PAN Y,ZHAO X,et al.Totaled health risks in vascular events score predicts clinical outcome and symptomatic intracranial hemorrhage in Chinese patients after thrombolysis[J].Stroke,2015,46(3):864-866.
[25] MAZYA M,EGIDO J A,FORD G A,et al.Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase:safe implementation of treatments in stroke(SITS) symptomatic intracerebral hemorrhage risk score[J].Stroke,2012,43(6):1524-1531.
[26] GUO Y,YANG Y,ZHOU M,et al.Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator:a systematic review and meta-analysis[J].Stroke Vasc Neurol,2018,3(4):203-208.
[27] 中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志，2019，52(4)：252-265.
[28] 梁志刚，杨绍婉，于国平.缺血性卒中静脉溶栓后症状性颅内出血研究进展[J].中国卒中杂志，2018，13(12)：1301-1308.
[29] CAPPELLARI M,TURCATO G,FORLIVESI S,et al.STARTING-SICH nomogram to predict symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke[J].Stroke,2018,49(2):397-404. |
